PPT1 Reduction Contributes to Erianin-Induced Growth Inhibition in Oral Squamous Carcinoma Cells
Authors:
Open Access
- 24 December 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9, 764263
Abstract
The anticancer properties of erianin have been recently discovered. However, the antitumor effect of erianin in oral squamous cell carcinoma (OSCC) remains unclear. In this study, we demonstrated that erianin can hamper OSCC cells growth both in vitro and in vivo. Erianin induced obvious G2/M arrest as well as apoptosis and gasdermin E (GSDME)-dependent pyroptosis in OSCC cells. Moreover, erianin increased autophagosome formation but decreased autolysosome function. Further study indicated that erianin significantly suppressed the expression of protein-palmitoyl thioesterase 1 (PPT1) and mTOR signaling. PPT1 has been reported to be a critical regulator of cancer progression by its modulation of autophagy and mTOR signaling. According to online databases, higher expression of PPT1 has been observed in OSCC tissues and is associated with poorer patient prognosis. As overexpression of PPT1 significantly reversed erianin-induced growth inhibition in OSCC cells, we identified the importance of PPT1 reduction in erianin-induced growth suppression. With the xenograft model, we confirmed the antitumor effect of erianin in vivo. Erianin efficiently decreased the tumor sizes, together with visibly reduced expression of PPT1 and phosphorylation of mTOR in the xenograft tumor tissues. Therefore, the present study indicated that erianin may be potentially used in OSCC therapy.Keywords
This publication has 36 references indexed in Scilit:
- Depalmitoylation by Palmitoyl-Protein Thioesterase 1 in Neuronal Health and DegenerationFrontiers in Synaptic Neuroscience, 2019
- Long-term speech and swallowing function after primary resection and sentinel node biopsy for early oral squamous cell carcinomaOral Oncology, 2019
- PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in CancerCancer Discovery, 2019
- Antibacterial interactions, anti-inflammatory and cytotoxic effects of four medicinal plant speciesBMC Complementary and Alternative Medicine, 2018
- NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinomaBMC Cancer, 2018
- A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling RolesCancer Discovery, 2017
- NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinomaJournal of Experimental & Clinical Cancer Research, 2017
- Erianin induces G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells in vitro and in vivoCell Death & Disease, 2016
- mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPaseScience, 2011
- Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).1995